Advisor Group Holdings, Inc. Theratechnologies Inc. Transaction History

Advisor Group Holdings, Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$0.78 - $1.01 $7,800 - $10,100	10,000 Added 2.3%	444,155 $373,000
Q4 2022 Feb 10, 2023	BUY	$0.83 - $8.04 $41,458 - $401,597	49,950 Added 13.0%	434,155 $382,000
Q3 2022 Nov 14, 2022	BUY	$1.98 - $2.42 $13,860 - $16,940	7,000 Added 1.86%	384,205 $911,000
Q2 2022 Aug 10, 2022	BUY	$2.21 - $2.7 $28,588 - $34,927	12,936 Added 3.55%	377,205 $856,000
Q1 2022 May 04, 2022	BUY	$2.37 - $3.24 $95,899 - $131,103	40,464 Added 12.5%	364,269 $892,000
Q3 2021 Nov 05, 2021	BUY	$3.28 - $4.07 $105,780 - $131,257	32,250 Added 11.06%	323,805 $1.21 Million
Q2 2021 Aug 02, 2021	BUY	$3.43 - $3.96 $403,923 - $466,337	117,762 Added 67.76%	291,555 $1.13 Million
Q1 2021 May 13, 2021	BUY	$2.2 - $3.94 $70,400 - $126,080	32,000 Added 22.57%	173,793 $672,000
Q4 2020 Feb 10, 2021	BUY	$1.91 - $2.5 $19,100 - $25,000	10,000 Added 7.59%	141,793 $354,000
Q3 2020 Nov 12, 2020	BUY	$1.96 - $2.92 $7,840 - $11,680	4,000 Added 3.13%	131,793 $291,000
Q2 2020 Aug 14, 2020	SELL	$1.58 - $2.86 $790 - $1,430	-500 Reduced 0.39%	127,793 $257,000
Q1 2020 May 18, 2020	BUY	$1.43 - $3.23 $183,458 - $414,386	128,293 New	128,293 $205,000

29.2K

Ticker THTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,141,600
Market Cap $116M
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.